Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWJ1252 vs Gasmotin in Functional Dyspepsia
NCT03184402Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Apr 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mosapride in functional dyspepsia (FD), sponsored by Daewoong Pharmaceutical. Started Apr 2017; status: completed.
02
Drugs
mosapride
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT03184402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03184402.